Holders — by stockHoldings — by fund
Blue Water Life Science Advisors, LP
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0001789778
$158.8M
disclosed book value
9
positions
21.4%
largest position share
Positions, as of 2026-06-30
top 9 of 9 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | CDNACAREDX INC | 1.2M | $33.9M | 21.4% |
| 2 | TXG10X GENOMICS INC | 642,000 | $24.6M | 15.5% |
| 3 | PSNLPERSONALIS INC | 1.7M | $22.5M | 14.1% |
| 4 | ADPTADAPTIVE BIOTECHNOLOGIES COR | 1.0M | $21.7M | 13.6% |
| 5 | GHGUARDANT HEALTH INC | 114,747 | $17.2M | 10.8% |
| 6 | QTRXQUANTERIX CORP | 3.5M | $15.0M | 9.5% |
| 7 | NTRANATERA INC | 34,494 | $9.4M | 5.9% |
| 8 | BLLNBILLIONTOONE INC | 70,000 | $8.4M | 5.3% |
| 9 | TEMTEMPUS AI INC | 105,412 | $6.1M | 3.8% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.